ATE307904T1 - Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit - Google Patents
Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheitInfo
- Publication number
- ATE307904T1 ATE307904T1 AT00991290T AT00991290T ATE307904T1 AT E307904 T1 ATE307904 T1 AT E307904T1 AT 00991290 T AT00991290 T AT 00991290T AT 00991290 T AT00991290 T AT 00991290T AT E307904 T1 ATE307904 T1 AT E307904T1
- Authority
- AT
- Austria
- Prior art keywords
- lsf
- lbp
- disease
- alzheimer
- relationship
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- AKWUNZFZIXEOPV-UHFFFAOYSA-N 2-[4-[[3-[7-chloro-1-(oxan-4-ylmethyl)indol-3-yl]-1,2,4-oxadiazol-5-yl]methyl]piperazin-1-yl]acetamide Chemical compound C1CN(CC(=O)N)CCN1CC1=NC(C=2C3=CC=CC(Cl)=C3N(CC3CCOCC3)C=2)=NO1 AKWUNZFZIXEOPV-UHFFFAOYSA-N 0.000 title 1
- 101100280477 Caenorhabditis elegans lbp-1 gene Proteins 0.000 title 1
- 101150116348 lbp-1 gene Proteins 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99403304A EP1113081A1 (de) | 1999-12-28 | 1999-12-28 | Zusammenhang des bekannten Gens CP2/LSF/LBP-1 mit Alzheimer |
| PCT/EP2000/013408 WO2001048240A2 (en) | 1999-12-28 | 2000-12-28 | Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307904T1 true ATE307904T1 (de) | 2005-11-15 |
Family
ID=8242236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00991290T ATE307904T1 (de) | 1999-12-28 | 2000-12-28 | Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030190631A1 (de) |
| EP (2) | EP1113081A1 (de) |
| JP (1) | JP2003518390A (de) |
| AT (1) | ATE307904T1 (de) |
| AU (1) | AU3165901A (de) |
| DE (1) | DE60023550D1 (de) |
| WO (1) | WO2001048240A2 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9408465D0 (en) * | 1994-04-27 | 1994-06-22 | Univ Mcgill | Apolipoprotein e polymorphism & treatment of alzheimer's disease |
| AU6435698A (en) * | 1997-02-20 | 1998-09-09 | Johns Hopkins School Of Medicine, The | Control of (il4) production as a therapeutic regulator of immune function |
| FR2765591B1 (fr) * | 1997-07-01 | 2002-08-09 | Pasteur Institut | Procede de diagnostic de la maladie d'alzheimer |
-
1999
- 1999-12-28 EP EP99403304A patent/EP1113081A1/de not_active Withdrawn
-
2000
- 2000-12-28 US US10/168,989 patent/US20030190631A1/en not_active Abandoned
- 2000-12-28 AU AU31659/01A patent/AU3165901A/en not_active Abandoned
- 2000-12-28 WO PCT/EP2000/013408 patent/WO2001048240A2/en not_active Ceased
- 2000-12-28 DE DE60023550T patent/DE60023550D1/de not_active Expired - Lifetime
- 2000-12-28 EP EP00991290A patent/EP1242629B1/de not_active Expired - Lifetime
- 2000-12-28 AT AT00991290T patent/ATE307904T1/de not_active IP Right Cessation
- 2000-12-28 JP JP2001548752A patent/JP2003518390A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1242629B1 (de) | 2005-10-26 |
| US20030190631A1 (en) | 2003-10-09 |
| DE60023550D1 (de) | 2005-12-01 |
| EP1242629A2 (de) | 2002-09-25 |
| JP2003518390A (ja) | 2003-06-10 |
| WO2001048240A3 (en) | 2001-12-06 |
| EP1113081A1 (de) | 2001-07-04 |
| AU3165901A (en) | 2001-07-09 |
| WO2001048240A2 (en) | 2001-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR18C1021I2 (fr) | Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle | |
| AU8448301A (en) | Remedies for heart failure | |
| CY1112261T1 (el) | Μεσο για τον προσδιορισμο του προφιλ κινδυνου ενος ατομου για την αθηροσκληρωτικη νοσο | |
| IL153052A0 (en) | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
| NO931889D0 (no) | Protease og beslektede dna-forbindelser | |
| DZ2557A1 (fr) | Appareil pour la production de courant de parcelles à haute vélocité. | |
| EP1272905A4 (de) | Verfahren und vorrichtung zum kompensieren einer dunkelverschiebung während der lebensdauer einer elektrofotografischen druckerpatrone | |
| IL124728A0 (en) | Diagnosis and treatment of aur-1 and/or aur-2 related disorders | |
| ATE487737T1 (de) | 32 humane sekretierte proteine | |
| ATE295423T1 (de) | Phosphodiesterase 8 | |
| NO974322L (no) | DNA som koder for human papillomvirus type 18 | |
| ATE307904T1 (de) | Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit | |
| PL330014A1 (en) | Application of genetic modification of the gene of human protein g subjunit beta3 in diagnosing diseases | |
| ATE230796T1 (de) | Obesitätsphänotyp erzeugendes gen | |
| AU2001270377A1 (en) | Transgenic animal model of neurodegenerative disorders | |
| ZA98656B (en) | Lage-1 tumer associated nucleic acids | |
| DE602005019540D1 (de) | Diagnostische und therapeutische verwendung des mal2-gens und proteins bei neurodegenerativen krankheiten | |
| ATE348109T1 (de) | Das gen prv-1 und dessen verwendung | |
| DE50311090D1 (de) | Repressor der skelettmuskeldifferenzierung, dafür kodierende nucleinsäure und dessen verwendung in diagnostik und therapie | |
| ATE247467T1 (de) | Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin | |
| DK0771786T3 (da) | Fremstilling af aryl- og vinylnitriler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |